These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis. Maretti E; Rossi T; Bondi M; Croce MA; Hanuskova M; Leo E; Sacchetti F; Iannuccelli V Int J Pharm; 2014 Feb; 462(1-2):74-82. PubMed ID: 24374224 [TBL] [Abstract][Full Text] [Related]
11. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Sharma R; Saxena D; Dwivedi AK; Misra A Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465 [TBL] [Abstract][Full Text] [Related]
12. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Nasr M; Awad GA; Mansour S; Taha I; Al Shamy A; Mortada ND Eur J Pharm Biopharm; 2011 Nov; 79(3):601-11. PubMed ID: 21827854 [TBL] [Abstract][Full Text] [Related]
13. Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis. Gupta A; Meena J; Sharma D; Gupta P; Gupta UD; Kumar S; Sharma S; Panda AK; Misra A Mol Pharm; 2016 Sep; 13(9):3247-55. PubMed ID: 27463245 [TBL] [Abstract][Full Text] [Related]
14. The application of high-content analysis in the study of targeted particulate delivery systems for intracellular drug delivery to alveolar macrophages. Lawlor C; O'Sullivan MP; Sivadas N; O'Leary S; Gallagher PJ; Keane J; Cryan SA Mol Pharm; 2011 Aug; 8(4):1100-12. PubMed ID: 21591762 [TBL] [Abstract][Full Text] [Related]
15. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245 [TBL] [Abstract][Full Text] [Related]
16. In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy. Parumasivam T; Chan JG; Pang A; Quan DH; Triccas JA; Britton WJ; Chan HK Mol Pharm; 2016 Mar; 13(3):979-89. PubMed ID: 26808409 [TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Devrim B; Bozkır A; Canefe K Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727 [TBL] [Abstract][Full Text] [Related]